163 related articles for article (PubMed ID: 38493053)
1. Prurigo: review of its pathogenesis, diagnosis, and treatment.
Criado PR; Ianhez M; Criado RFJ; Nakano J; Lorenzini D; Miot HA
An Bras Dermatol; 2024 Mar; ():. PubMed ID: 38493053
[TBL] [Abstract][Full Text] [Related]
2. [Update on the treatment of chronic prurigo].
Zeidler C; Pereira MP; Ständer S
Dermatologie (Heidelb); 2022 Aug; 73(8):614-619. PubMed ID: 35925236
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors.
Gael M; Adam T; Mariano-Bourin M; Bursztejn AC
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1541-1551. PubMed ID: 35569006
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real-life observational study.
Fang HY; Lian CH
J Dermatol; 2023 Aug; 50(8):1084-1087. PubMed ID: 37088954
[TBL] [Abstract][Full Text] [Related]
5. Chronic prurigo.
Misery L
Br J Dermatol; 2022 Oct; 187(4):464-471. PubMed ID: 35656799
[TBL] [Abstract][Full Text] [Related]
6. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors.
Nakashima C; Yanagihara S; Otsuka A
Allergol Int; 2022 Jan; 71(1):40-46. PubMed ID: 34815171
[TBL] [Abstract][Full Text] [Related]
7. Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.
Chiricozzi A; Maurelli M; Gori N; Argenziano G; De Simone C; Calabrese G; Girolomoni G; Peris K
J Am Acad Dermatol; 2020 Jul; 83(1):39-45. PubMed ID: 32229281
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life.
Richter C; Hafner J; Schuermann M; Tanadini M; Trisconi N; Schmid-Grendelmeier P; Kündig T; Nägeli M; Brüggen MC; Guillet C
Dermatology; 2023; 239(5):811-817. PubMed ID: 37369187
[TBL] [Abstract][Full Text] [Related]
9. A critical review of dupilumab for adult patients with prurigo nodularis.
Biazus Soares G; Yosipovitch G
Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment of chronic prurigo with dupilumab].
Winkler JK; Haenssle HA; Enk A; Toberer F; Hartmann M
Hautarzt; 2021 Jun; 72(6):528-532. PubMed ID: 33180178
[TBL] [Abstract][Full Text] [Related]
11. Treatment-resistant prurigo nodularis: challenges and solutions.
Kowalski EH; Kneiber D; Valdebran M; Patel U; Amber KT
Clin Cosmet Investig Dermatol; 2019; 12():163-172. PubMed ID: 30881076
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
Takeuchi S; Inoue K; Kuretake K; Kiyomatsu-Oda M; Furue M
J Dermatol; 2021 May; 48(5):638-644. PubMed ID: 33742710
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis.
Napolitano M; Fabbrocini G; Scalvenzi M; Nisticò SP; Dastoli S; Patruno C
Dermatitis; 2020; 31(1):81-84. PubMed ID: 31517666
[TBL] [Abstract][Full Text] [Related]
14. Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series.
Wieser JK; Mercurio MG; Somers K
Cureus; 2020 Jun; 12(6):e8737. PubMed ID: 32714676
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy.
Ferrucci S; Tavecchio S; Berti E; Angileri L
J Dermatolog Treat; 2021 Jun; 32(4):453-454. PubMed ID: 31442084
[TBL] [Abstract][Full Text] [Related]
16. Chronic Pruritus Responding to Dupilumab-A Case Series.
Zhai LL; Savage KT; Qiu CC; Jin A; Valdes-Rodriguez R; Mollanazar NK
Medicines (Basel); 2019 Jun; 6(3):. PubMed ID: 31261951
[TBL] [Abstract][Full Text] [Related]
17. [THREE CASES OF ATOPIC DERMATITIS CHILDREN WITH INTRACTABLE PRURIGO NODULARIS].
Murakami Y; Sugiyama A; Ideguchi H; Murakami Y; Amimoto Y; Nishie H; Odajima H
Arerugi; 2020; 69(3):213-217. PubMed ID: 32435023
[TBL] [Abstract][Full Text] [Related]
18. 2020 guidelines for the diagnosis and treatment of prurigo.
Satoh T; Yokozeki H; Murota H; Tokura Y; Kabashima K; Takamori K; Shiohara T; Morita E; Aiba S; Aoyama Y; Hashimoto T; Katayama I
J Dermatol; 2021 Sep; 48(9):e414-e431. PubMed ID: 34314056
[TBL] [Abstract][Full Text] [Related]
19. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Huang IH; Chung WH; Wu PC; Chen CB
Front Immunol; 2022; 13():1068260. PubMed ID: 36569854
[TBL] [Abstract][Full Text] [Related]
20. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Husein-ElAhmed H; Steinhoff M
J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
